Vestmark Advisory Solutions’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.89M Sell
45,526
-33,131
-42% -$3.56M 0.07% 205
2025
Q1
$7.93M Buy
78,657
+35,721
+83% +$3.6M 0.2% 131
2024
Q4
$3.84M Sell
42,936
-894
-2% -$79.9K 0.13% 162
2024
Q3
$3.67M Buy
43,830
+6,066
+16% +$508K 0.14% 153
2024
Q2
$2.91M Buy
37,764
+288
+0.8% +$22.2K 0.12% 186
2024
Q1
$2.57M Sell
37,476
-1,501
-4% -$103K 0.11% 212
2023
Q4
$2.25M Sell
38,977
-339
-0.9% -$19.6K 0.11% 210
2023
Q3
$2.08M Buy
39,316
+22,900
+139% +$1.21M 0.15% 168
2023
Q2
$888K Sell
16,416
-976
-6% -$52.8K 0.03% 480
2023
Q1
$870K Buy
17,392
+336
+2% +$16.8K 0.04% 469
2022
Q4
$789K Buy
17,056
+5,135
+43% +$238K 0.04% 476
2022
Q3
$462K Sell
11,921
-183
-2% -$7.09K 0.03% 552
2022
Q2
$451K Sell
12,104
-370
-3% -$13.8K 0.03% 564
2022
Q1
$552K Buy
12,474
+395
+3% +$17.5K 0.03% 506
2021
Q4
$513K Sell
12,079
-2,871
-19% -$122K 0.03% 538
2021
Q3
$649K Buy
14,950
+279
+2% +$12.1K 0.04% 425
2021
Q2
$627K Sell
14,671
-7,468
-34% -$319K 0.04% 415
2021
Q1
$856K Buy
22,139
+2,685
+14% +$104K 0.08% 328
2020
Q4
$699K Buy
19,454
+1,946
+11% +$69.9K 0.08% 295
2020
Q3
$669K Buy
17,508
+2,154
+14% +$82.3K 0.09% 274
2020
Q2
$539K Buy
15,354
+1,664
+12% +$58.4K 0.08% 286
2020
Q1
$447K Buy
13,690
+203
+2% +$6.63K 0.09% 286
2019
Q4
$610K Sell
13,487
-1,423
-10% -$64.4K 0.13% 192
2019
Q3
$607K Buy
14,910
+47
+0.3% +$1.91K 0.1% 259
2019
Q2
$639K Sell
14,863
-905
-6% -$38.9K 0.11% 242
2019
Q1
$605K Buy
+15,768
New +$605K 0.11% 247